Overview
- 62 inspections across 60 sites are on record.
- 192 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-15.
At a glance
Inspections
62
Sites
60
Observations
192
Career since
Mar 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Emcure Pharmaceuticals Limited | 15 May 2026 | Human Drugs | On file |
| Zydus Lifesciences Limited | 5 May 2026 | Human Drugs | On file |
| Catalent Indiana, LLC | 24 Apr 2026 | Human Drugs | On file |
| Bora Pharmaceuticals Injectables Inc | 20 Mar 2026 | Human Drugs | On file |
| Alcami Carolinas Corporation | 6 Feb 2026 | Human Drugs | View 483 → |
Sites inspected
Emcure Pharmaceuticals LimitedAhmedabad, India1 insp.
Zydus Lifesciences LimitedAhmedabad, India1 insp.
Catalent Indiana, LLCBloomington, United States1 insp.
Bora Pharmaceuticals Injectables IncBaltimore, United States1 insp.
Alcami Carolinas CorporationCharleston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Bijoy Panicker7 shared
Jessica S Estriplet6 shared
Sena G Dissmeyer5 shared
Karen A Briggs4 shared
Mindy M Chou3 shared
Anastasia M Shields3 shared
Sony Mathews3 shared
Tanya R Syffrard3 shared
Christina K Theodorou2 shared
Jennifer L Huntington2 shared
Full investigator report
Get the verbatim findings behind Brandy N Lepage's 192 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site